English to Portuguese Other Education / Pedagogy Educação física/imagem

29) Provide Lupus-PRO questionnaire to subjects for completion (US sites only)
30) Perform SLEDAI-2K
31) Perform MDGA
32) Administer sifalimumab
33) Take vital signs approximately every 15 minutes during administration of the investigational product, immediately after the infusion (within 10 minutes after the infusion has stopped), and approximately every 30 minutes after the completion of the infusion until vital signs are stable, and/or the investigator considers the subject to be clinically stable.
34) Take blood pressure and heart rate immediately prior to discharge from the site